TReP-132 Is a Novel Progesterone Receptor Coactivator Required for the Inhibition of Breast Cancer Cell Growth and Enhancement of Differentiation by Progesterone
Molecular and Cellular Biology - United States
doi 10.1128/mcb.00326-06
Full Text
Open PDFAbstract
Available in full text
Date
October 2, 2006
Authors
Publisher
American Society for Microbiology